Related Experiment Video
Updated: Jul 25, 2026
06:55
Scanning Light Scattering Profiler (SLPS) Based Methodology to Quantitatively Evaluate Forward and Backward Light Scattering from Intraocular Lenses
Published on: June 6, 2017
The IOLAB, Inc pediatric intraocular lens study. AAPOS Reasearch Committee. American Association for Pediatric
Summary
Pediatric intraocular lens (IOL) implantation shows promise for treating aphakia, with over half of eyes achieving 20/40 vision within a year. However, significant follow-up loss compromises long-term safety and efficacy data.
Area of Science:
- Ophthalmology
- Pediatric Medicine
- Surgical Innovation
Background:
- Pediatric aphakia presents unique challenges requiring effective treatment solutions.
- Intraocular lens (IOL) implantation is a potential surgical option for visual rehabilitation in children.
Purpose of the Study:
- To evaluate the safety and efficacy of IOL implantation in pediatric eyes.
- To gather data for Food and Drug Administration (FDA) approval of pediatric IOLs.
Main Methods:
- A national study involving 1260 pediatric eyes implanted with 171 IOL styles by 361 investigators.
- Data collection included preoperative, operative, and postoperative reports up to 1 year, with subsequent annual follow-ups.
- Study duration spanned from May 1981 to November 1995.
Main Results:
- Postoperative visual acuity data were available for 563 eyes at 1 year; 52.8% achieved 20/40 or better.
- Congenital cataracts (45.6%) and traumatic cataracts (37.1%) were the primary indications.
- Posterior chamber IOLs were most common (93.6%), with 130 adverse reactions requiring secondary surgery.
Conclusions:
- Pediatric IOL implantation appears to be a viable treatment for aphakia based on 1-year follow-up data.
- Study limitations include significant loss to follow-up (nearly 50% at 1 year) and evolving surgical techniques.
- Factors like cataract type, surgical approach, and IOL design influenced outcomes.
